Allozyne

Protein therapeutics for CNS diseases such as multiple sclerosis.

placeSeattle, Washington, United States calendar_todayFounded 2005 groups6 employees language allozyne.com

Registered entities

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%
Coming soon